Mark VanDer Lugt practices Pediatric Hematology & Oncology. He studied medicine at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54 in research and 62 in primary care medicine Mark VanDer Lugt has written publications. He has 1 publication published with PubMed. The lastest publication is: 'Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Sub-Acute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation.'
![]() |
Dr. Susan E. Creary, MD
![]() ![]() |
![]() |
Dr. Erika Friehling, MD
![]() |
![]() |
Dr. Regina I. Jakacki, MD
![]() ![]() |
![]() |
Dr. Michael R. Wollman, MD
![]() ![]() |
![]() |
Dr. Randy M. Windreich, MD
![]() ![]() |
![]() |
Dr. Jean M. Tersak, MD
![]() ![]() |
![]() |
Dr. Angela R. Girvin, MD
![]() |
![]() |
Dr. Sriya W. Gunawardena, MD
![]() ![]() |
![]() |
Dr. Paul T. Finch, MD
![]() |
![]() |
Dr. Vincent C. Albo, MD
![]() ![]() |